Camson Bio Tech.

Camson_Bio_Tech.11 May 2020

Miscellaneous

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Camson Bio Tech.

Camson Bio Tech.

Miscellaneous

Camson_Bio_Tech.11 May 2020

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-May-2014	D	Camson Bio Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2014, inter alia, transacted the following business subject to approval of the Shareholders in the General Meeting : 1. Recommended dividend of Re. 1/- per Equity Share (10%) of face value of Rs. 10/- each.	15-Sep-2014
31-May-2013	D	Camson Bio Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has approved the following business, subject to approval of the Shareholders in the General Meeting; 1. Recommended dividend of Re. 1 per share (10%) of face value of Rs. 10 each.	19-Sep-2013
31-Aug-2012	D	Camson Bio Technologies Ltd has informed BSE that the meeting of the Board of Directors of the Company which was scheduled to be held on August 28, 2012 had been postponed to August 30, 2012. Further, at the Board Meeting held on August 30, 2012, the Board, inter alia, has transacted the following business: 1. Recommended dividend Re. 1/- per Share (@10%) for the year 2011-12.	24-Sep-2012
29-Aug-2011	D	Camson Bio Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 27, 2011, inter alia, has recommended the dividend @ 10% (Re. 1/- per share) for the year 2010-11.	23-Sep-2011
30-Aug-2010	D	Camson Bio Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 30, 2010, inter alia, has recommended the dividend at the rate of 10% (Rs. 1 for every equity share).	21-Sep-2010
04-May-2020	BC	This is in continuation to Exchange Notice No. 20190927-33 dated September 27, 2019 wherein the Trading Members were advised that w.r.t to the following companies, 15 days after suspension had been e	12-May-2020
27-Sep-2019	BC	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2018/77 dated May 3, 2018 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (SOP) f	22-Oct-2019
16-Oct-2019	BC	With reference to the captioned matter, we wish to inform that Mr. Virendra Kumar Singh (DIN: 07226146) and Mr. Manoj Srivastava (DIN: 00513960), Independent Directors of the Company has resigned fro	16-Oct-2019
16-Oct-2019	BC	With reference to the captioned matter, we wish to inform that Mr. Peter Joseph Kennedy, Non-Executive Director of the Company (DIN: 06377043) and Ms. Geok Lan Tay, Non-Executive Director of the Comp	15-Oct-2019
30-Sep-2019	BC	We wish to inform that Mr. Karan Singh, Non-Executive Director of the Company (DIN: 00920982) has resigned from his position w.e.f. 28th September, 2019, owing to some pre-occupation elsewhere and is	28-Sep-2019

No Rights has been declared by Camson_Bio_Tech.

Book Closure

Record Date	Split Date	Purpose
12-May-2020	-	This is in continuation to Exchange Notice No. 20190927-33 dated September 27, 2019 wherein the Trading Members were advised that w.r.t to the following companies, 15 days after suspension had been e
22-Oct-2019	-	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2018/77 dated May 3, 2018 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (SOP) f
16-Oct-2019	-	With reference to the captioned matter, we wish to inform that Mr. Virendra Kumar Singh (DIN: 07226146) and Mr. Manoj Srivastava (DIN: 00513960), Independent Directors of the Company has resigned fro
15-Oct-2019	-	With reference to the captioned matter, we wish to inform that Mr. Peter Joseph Kennedy, Non-Executive Director of the Company (DIN: 06377043) and Ms. Geok Lan Tay, Non-Executive Director of the Comp
28-Sep-2019	-	We wish to inform that Mr. Karan Singh, Non-Executive Director of the Company (DIN: 00920982) has resigned from his position w.e.f. 28th September, 2019, owing to some pre-occupation elsewhere and is

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Camson Bio Technologies Ltd ₹3.31(0.00/0.00%)	3.31	+0.00	9.93	-56.45	0.00	0.22
MPIL Corporation Ltd ₹805.95(-42.40/-5.00%)	805.95	-42.40	45.94	207.03	69.60	2.98
Jaykay Enterprises Ltd ₹129.45(-4.00/-3.00%)	129.45	-4.00	756.73	155.28	128.17	5.28
Modi Rubber Ltd ₹100.00(+2.35/2.41%)	100.00	+2.35	250.40	65.18	11.35	0.66
FGP Ltd ₹7.40(+0.34/4.82%)	7.40	+0.34	8.81	24.37	0.00	2.76
TCI Industries Ltd ₹1,408.50(+56.15/4.15%)	1,408.50	+56.15	126.77	10.91	0.00	13.73

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
Gross Sales	1.19	0.59	1.58	1.52	1.29	-0.51
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1.19	0.59	1.58	1.52	1.29	-0.51
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.82	2.31	0.06	0.00	-0.24
Total Income	1.19	1.41	3.89	1.58	1.29	-0.75
Total Expenditure	6.72	15.38	1.24	2.90	1.85	2.47
PBIDT	-5.53	-13.97	2.66	-1.32	-0.56	-3.22
Interest	0.29	-4.97	2.11	2.27	1.73	-0.06
PBDT	-5.82	-9.00	0.54	-3.59	-2.29	-3.16
Depreciation	1.73	1.71	1.76	1.76	1.74	1.75
Tax	0.00	0.59	-0.57	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.34	0.23	0.00
Reported Profit After Tax	-7.54	-11.30	-0.65	-5.69	-4.26	-4.90
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-7.54	-11.30	-0.65	-5.69	-4.26	-4.90

EPS (Unit Curr.)	-2.51	-3.77	-0.22	-1.90	-1.42	-1.63
EPS (Adj) (Unit Curr.)	-2.51	-3.77	-0.22	-1.90	-1.42	-1.63
Calculated EPS (Unit Curr.)	-2.51	-3.77	-0.22	-1.90	-1.42	-1.63
Calculated EPS (Adj) (Unit Curr.)	-2.51	-3.77	-0.22	-1.90	-1.42	-1.63
Calculated EPS (Ann.) (Unit Curr.)	-10.06	-15.07	-0.86	-7.58	-5.68	-6.54
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-10.06	-15.07	-0.86	-7.58	-5.68	-6.54
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	30.00	30.00	30.00	30.00	30.00	30.00
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-464.71	-2367.80	168.35	-86.84	-43.41	631.37
PBDTM(%)	-489.08	-1525.42	34.18	-236.18	-177.52	619.61
PATM(%)	-633.61	-1915.25	-41.14	-374.34	-330.23	960.78

Column	Mar 15	Dec 14	Sep 14	Jun 14	Mar 14	Dec 13
Gross Sales	46.17	63.51	47.10	46.24	39.49	54.20
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	46.17	63.51	47.10	46.24	39.49	54.20
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	5.90	0.35	0.15	0.02	0.04	0.05
Total Income	52.07	63.86	47.25	46.26	39.54	54.26
Total Expenditure	50.85	55.99	42.39	39.04	30.30	49.42
PBIDT	1.22	7.88	4.86	7.22	9.24	4.83
Interest	2.08	1.02	0.84	1.15	1.22	0.90
PBDT	-0.86	6.85	4.02	6.07	8.02	3.93
Depreciation	3.79	3.51	3.36	3.34	1.35	1.28
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.87	1.90	0.44	-1.23	-1.36	0.22
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-5.52	1.45	0.22	3.96	8.04	2.43
Minority Interest After NP	-1.46	-0.30	-0.01	-0.05	-0.02	0.00
Net Profit after Minority Interest	-4.06	1.75	0.23	4.01	8.05	2.43

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-4.06	1.75	0.23	4.01	8.05	2.43

EPS (Unit Curr.)	-1.41	0.58	0.08	1.41	2.68	0.96
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	30.00	30.00	30.00	28.33	25.23	25.23

Public Shareholding (Number)	22661240.00	22661240.00	22661240.00	20986913.00	18586913.00	18586913.00
Public Shareholding (%)	75.54	75.54	75.54	74.09	73.68	73.68

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	7338600.00	7338600.00	7338600.00	7338600.00	6638600.00	6638600.00
Non Encumbered - % in Total Promoters Holding	100.00	100.00	100.00	100.00	100.00	100.00
Non Encumbered - % in Total Equity	24.46	24.46	24.46	25.91	26.32	26.32

PBIDTM(%)	2.64	12.41	10.32	15.61	23.40	8.91
PBDTM(%)	-1.86	10.79	8.54	13.13	20.31	7.25
PATM(%)	-11.96	2.28	0.47	8.56	20.36	4.48

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15	Mar 14
SOURCES OF FUNDS :
Share Capital	30.00	30.00	30.00	30.00	30.00	25.23
Reserves Total	14.75	36.66	47.03	74.24	233.98	178.63
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	23.11
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	44.75	66.66	77.03	104.24	263.98	226.97
Secured Loans	22.61	24.62	31.44	27.54	32.00	35.10
Unsecured Loans	27.22	24.12	14.49	19.65	4.74	4.64
Total Debt	49.83	48.74	45.93	47.19	36.74	39.74
Total Liabilities	94.58	115.40	122.96	151.43	300.72	266.71
APPLICATION OF FUNDS :
Gross Block	148.31	148.30	147.89	151.41	166.51	124.32
Less : Accumulated Depreciation	66.97	60.00	41.60	34.57	27.96	14.72
Less:Impairment of Assets	0.00	0.00	11.21	11.21	0.00	0.00
Net Block	81.34	88.30	95.08	105.63	138.55	109.60
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.01
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3.40	3.40	3.40	5.98	0.01	0.01
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	25.88	40.44	12.00	9.24	25.34	39.98
Sundry Debtors	6.57	5.11	3.72	16.60	147.25	84.01
Cash and Bank	0.06	0.09	0.23	0.30	1.03	1.92
Loans and Advances	2.45	1.33	1.25	0.46	5.55	4.68
Total Current Assets	34.96	46.97	17.20	26.60	179.17	130.59
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	19.63	19.07	16.08	14.80	16.74	9.70
Provisions	5.89	5.23	5.86	2.95	2.84	3.51
Total Current Liabilities	25.52	24.29	21.93	17.74	19.58	13.21
Net Current Assets	9.44	22.68	-4.74	8.85	159.59	117.38
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.18	1.18	1.18	1.18	0.00	0.99
Deferred Tax Liability	0.00	0.00	0.00	0.00	1.78	0.89
Net Deferred Tax	1.18	1.18	1.18	1.18	-1.78	0.10
Total Assets	95.35	115.56	94.92	121.63	296.37	227.10
Contingent Liabilities	0.00	0.00	16.53	16.02	22.07	0.00

Column	Mar 18	Mar 17	Mar 16	Mar 15	Mar 14	Mar 13
SOURCES OF FUNDS :
Share Capital	30.00	30.00	30.00	30.00	25.23	18.13
Reserves Total	36.66	45.10	71.63	233.25	179.04	128.87
Equity Share Warrants	0.00	0.00	0.00	0.00	23.11	14.80
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	66.66	75.10	101.63	263.25	227.38	161.80
Minority Interest	0.00	0.00	2.26	2.93	0.26	0.27
Secured Loans	24.58	31.44	41.34	35.79	35.10	37.62
Unsecured Loans	24.17	14.49	19.88	11.40	4.64	3.18
Total Debt	48.75	45.93	61.22	47.19	39.74	40.80
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	1.93	2.29	2.90	3.39	2.46	1.85
Total Liabilities	117.34	123.32	168.01	316.76	269.84	204.72
APPLICATION OF FUNDS :
Gross Block	148.30	147.89	167.10	181.93	124.33	88.06
Less: Accumulated Depreciation	48.79	41.60	36.67	28.56	14.72	9.64
Less: Impairment of Assets	11.21	11.21	11.21	0.00	0.00	0.00
Net Block	88.30	95.08	119.22	153.37	109.61	78.42
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.01	0.01	0.01	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3.40	1.47	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	40.44	12.00	10.89	27.97	40.41	39.59
Sundry Debtors	5.11	3.72	28.62	159.51	93.55	80.58
Cash and Bank	0.26	0.21	0.59	1.46	1.96	1.69
Loans and Advances	1.16	1.21	2.09	5.43	4.82	8.90
Total Current Assets	46.97	17.13	42.19	194.36	140.74	130.76
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	19.07	16.08	24.29	28.12	17.35	24.26
Provisions	5.23	5.86	2.96	2.85	4.11	3.18
Total Current Liabilities	24.29	21.93	27.24	30.96	21.46	27.44
Net Current Assets	22.68	-4.80	14.95	163.40	119.28	103.32
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.18	1.18	1.18	0.85	1.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	2.63	0.89	0.82
Net Deferred Tax	1.18	1.18	1.18	-1.78	0.11	-0.82
Other Assets	1.78	30.40	32.65	1.74	40.81	23.81
Total Assets
Contingent Liabilities	20.41	16.53	16.02	22.00	0.00	0.07

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash and Cash Equivalents at Beginning of the year	0.09	0.06	0.10	0.57	1.46
Net Cash from Operating Activities	0.00	1.83	4.56	-9.99	14.12
Net Cash Used In Investing Activities	-0.01	0.73	2.72	5.29	-43.31
Net Cash Used In Financing Activities	-0.02	-2.53	-7.33	4.23	28.30
Net Inc./Dec In Cash And Cash Equivalents	-0.03	0.03	-0.04	-0.47	-0.89
Cash And Cash Equivalents At End Of The Year	0.06	0.09	0.06	0.10	0.57

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

24.46%

FII Shareholding

19.57%

DII Shareholding

0.00%

Public Shareholding

55.97%

**Promoter pledged shareholding 24.46%

About Camson Bio Technologies Ltd

Camson Bio Technologies Ltd is in the Miscellaneous sector, having a market capitalization of Rs. 9.93 crores. It has reported a sales of Rs. 1.19 crores and a net profit of Rs. -7.54 crores for the quarter ended December 2018. The company management includes , Dhirendra Kumar (Camson Bio Technologies Ltd) among others.

Chairman

Registered office

C-7 7t Floor Corporate Block,Golden Enclave Old Airport Rd,Bangalore,Karnataka,560017

FAX :080-40768905

Background

Incorporation Year1993

Face Value₹10

Market Lot1

How to buy Camson Bio Tech. shares on nse?

To buy Camson Bio Tech. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Camson Bio Tech. share price today?

The Camson Bio Tech. shares price on nse is Rs.3.31 today.

What is the market cap of Camson Bio Tech. shares on BSE ?

The company has a market capitalization of Rs.9.93Cr

What is the PE & PB ratio of Camson Bio Tech. shares ?

PE is 0 and PB is 0.22

What is the 52 Week High and Low of Camson Bio Tech. shares?

Camson Bio Tech. stock price high: Rs.3.31 Camson Bio Tech. stock price low: Rs.0